Cytek Biosciences, Inc.CTKBNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank17
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P17
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-118.46%
2024380.57%
2023143.18%
2022-364.17%
2021-69.45%
2020210.25%
20190.00%